" /> CDK Inhibitor AT7519 - CISMeF





Preferred Label : CDK Inhibitor AT7519;

NCIt synonyms : Cyclin-Dependent Kinase Inhibitor AT7519M;

NCIt related terms : CDKI AT7519; AT7519M; CDK inhibitor AT7519M; AT-7519;

NCIt definition : An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. CDKs are serine/threonine kinases involved in regulation of the cell cycle and may be overexpressed in some types of cancer cells.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of some types of cancer. AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor.;

UNII : X1BF92PW9T;

CAS number : 844442-38-2;

Molecule name : AT7519; AT7519M;

Chemical formula : C16H17Cl2N5O2;

Codes from synonyms : CDR0000530319; CDR0000546733;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.